AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Laurus Labs Limited Capital/Financing Update 2024

Dec 20, 2024

62639_rns_2024-12-20_6996a717-2402-4338-b9c1-60537507022a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [190 x 81] intentionally omitted <==

December 20, 2024

ToThe Corporate Relations DepartmentBSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001Code: 540222	ToThe Listing DepartmentNational Stock Exchange of India Ltd.,Exchange Plaza,Bandra Kurla Complex, Bandra (E),Mumbai – 400 051Code: LAURUSLABS

Sub: Update on investment in Laurus Bio Private Limited (Subsidiary Company) under Regulation 30(7) of SEBI (LODR) Regulations, 2015

Ref: Our letter dated December 06, 2024

Dear Sir / madam,

With respect to above cited subject and reference and as per Regulation 30(7) of SEBI (LODR) Regulations, 2015, we would like to inform you that Eight Roads Ventures and F-Prime Capital (“Investors”) have together invested Rupees 120 Crores in Laurus Bio Private Limited, a subsidiary company of Laurus Labs Limited and the said transaction of the Investors was completed today i.e. on December 20, 2024.

Please take the above information on record.

Yours faithfully,

For Laurus Labs Limited